A1 Refereed original research article in a scientific journal

Cutting edge: Transcriptional activity of NFATc1 is enhanced by the Pim-1 kinase




AuthorsRainio EM, Sandholm J, Koskinen PJ

PublisherAMER ASSOC IMMUNOLOGISTS

Publication year2002

JournalJournal of Immunology

Journal name in sourceJOURNAL OF IMMUNOLOGY

Journal acronymJ IMMUNOL

Volume168

Issue4

First page 1524

Last page1527

Number of pages4

ISSN0022-1767

DOIhttps://doi.org/10.4049/jimmunol.168.4.1524


Abstract
Pim-1 is an oncogenic serine/threonine kinase implicated in cytokine-induced signal transduction and in development of lymphoid malignancies. However, its precise function as well as physiological substrates have remained unknown. In this study we demonstrate that Pim-1 can physically interact with the NFATc1 transcription factor and phosphorylate it in vitro on several serine residues. In contrast to previously recognized NFATc kinases, wild-type Pim-1 enhances NFATc-dependent transactivation and IL-2 production in Jurkat T cells, while kinase-deficient Pim-1 mutants inhibit them in a dominant negative fashion. Our results reveal a novel, phosphorylation-dependent regulatory mechanism targeting NFATc1 through which Pim-1 acts as a downstream effector of Ras to facilitate IL-2-dependent proliferation and/or survival of lymphoid cells.

Downloadable publication

This is an electronic reprint of the original article.
This reprint may differ from the original in pagination and typographic detail. Please cite the original version.





Last updated on 2024-26-11 at 17:41